SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.
14 Citations
132 Claims
-
1-104. -104. (canceled)
- 105. A crystal form of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, characterized by one or more peaks at about 6.2, about 7.6, about 12.3, and about 18.0 degrees in an X-ray powder diffraction pattern obtained using Cu K alpha radiation (2Θ
-
124. (canceled)
-
127. (canceled)
-
128. (canceled)
-
129. A crystal form of N-[2,4-bis(1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, having a monoclinic crystal system, a P21 space grouping, and the following unit cell dimensions:
-
a=11.8011(7) Å
α
=90°b=5.9819(3) Å
β
=105.110(4)°c=14.7974(8) Å
γ
=90°
.
-
-
131. (canceled)
Specification